Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

The FMS-like tyrosine kinase 3 (FLT3) gene is mutated in 25-30% of patients with acute myeloid leukemia (AML). Because of the poor prognosis associated with FLT3-internal tandem duplication mutated AML, allogeneic hematopoietic stem-cell transplantation (SCT) was commonly performed in first complete...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Haematologica
المؤلفون الرئيسيون: Bazarbachi, Ali, Bug, Gesine, Baron, Frederic, Brissot, Eolia, Ciceri, Fabio, Dalle, Iman Abou, Döhner, Hartmut, Esteve, Jordi, Floisand, Yngvar, Giebel, Sebastian, Gilleece, Maria, Gorin, Norbert-Claude, Jabbour, Elias, Aljurf, Mahmoud, Kantarjian, Hagop, Kharfan-Dabaja, Mohamed, Labopin, Myriam, Lanza, Francesco, Malard, Florent, Peric, Zinaida, Prebet, Thomas, Ravandi, Farhad, Ruggeri, Annalisa, Sanz, Jaime, Schmid, Christoph, Shouval, Roni, Spyridonidis, Alexandros, Versluis, Jurjen, Vey, Norbert, Savani, Bipin N, Nagler, Arnon, Mohty, Mohamad
التنسيق: Artigo
اللغة:Inglês
منشور في: Ferrata Storti Foundation 2020
الموضوعات:
Guideline Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7271578/
https://ncbi.nlm.nih.gov/pubmed/32241850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.243410
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة